glp 1 ra Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care Could GLP-1 Receptor Agonists Help

Welcome to day six of my peptide journey

This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos

At the moment, our main focus is on oncological, neurological and rare diseases

This material is not intended to be relied upon as a forecast, research or investment advice, and it is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy